{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:50:08Z","timestamp":1793897408610,"version":"4.8.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,11,1]]},"DOI":"10.1001\/jamaophthalmol.2019.3278","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T11:32:11Z","timestamp":1567078331000},"page":"1247","source":"Crossref","is-referenced-by-count":90,"title":["Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia"],"prefix":"10.1001","volume":"137","author":[{"given":"M. Dominik","family":"Fischer","sequence":"first","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Institute for Ophthalmic Research, Centre for Ophthalmology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"STZ eyetrial at the Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alex","family":"Ochakovski","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Institute for Ophthalmic Research, Centre for Ophthalmology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Beier","sequence":"additional","affiliation":[{"name":"STZ eyetrial at the Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immanuel P.","family":"Seitz","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Institute for Ophthalmic Research, Centre for Ophthalmology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousof","family":"Vaheb","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Kortuem","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix F. L.","family":"Reichel","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Institute for Ophthalmic Research, Centre for Ophthalmology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kuehlewein","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine A.","family":"Kahle","sequence":"additional","affiliation":[{"name":"STZ eyetrial at the Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Peters","sequence":"additional","affiliation":[{"name":"STZ eyetrial at the Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniz","family":"Girach","sequence":"additional","affiliation":[{"name":"Nightstar Therapeutics, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhart","family":"Zrenner","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Institute for Ophthalmic Research, Centre for Ophthalmology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ueffing","sequence":"additional","affiliation":[{"name":"Institute for Ophthalmic Research, Centre for Ophthalmology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom"},{"name":"Nightstar Therapeutics, London, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom"},{"name":"Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[{"name":"University Eye Hospital, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wilhelm","sequence":"additional","affiliation":[{"name":"STZ eyetrial at the Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9923","key":"eoi190059r1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial.","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"eoi190059r2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/13816810.2011.620056","article-title":"Choroideremia: a review of general findings and pathogenesis.","volume":"33","author":"Coussa","year":"2012","journal-title":"Ophthalmic Genet"},{"issue":"9","key":"eoi190059r3","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1167\/iovs.06-0424","article-title":"Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.","volume":"47","author":"Jacobson","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5093","key":"eoi190059r4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.8380507","article-title":"Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase.","volume":"259","author":"Seabra","year":"1993","journal-title":"Science"},{"key":"eoi190059r5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2017.05.002","article-title":"Measurement and reproducibility of preserved ellipsoid zone area and preserved retinal pigment epithelium area in eyes with choroideremia.","volume":"179","author":"Hariri","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi190059r6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1566523217666171116170040","article-title":"The role of gene therapy in the treatment of retinal diseases: a review.","volume":"17","author":"Campa","year":"2017","journal-title":"Curr Gene Ther"},{"issue":"5","key":"eoi190059r7","doi-asserted-by":"crossref","DOI":"10.1088\/1741-2552\/aa7a27","article-title":"Gene therapy for inherited retinal degenerations: initial successes and future challenges.","volume":"14","author":"Gupta","year":"2017","journal-title":"J Neural Eng"},{"issue":"20","key":"eoi190059r8","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia.","volume":"374","author":"Edwards","year":"2016","journal-title":"N Engl J Med"},{"key":"eoi190059r9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2018.06.011","article-title":"Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience.","volume":"193","author":"Dimopoulos","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"eoi190059r11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41591-018-0185-5","article-title":"Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia.","volume":"24","author":"Xue","year":"2018","journal-title":"Nat Med"},{"key":"eoi190059r13","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000002360","article-title":"Changes in retinal sensitivity after gene therapy in choroideremia.","author":"Fischer","year":"2018","journal-title":"Retina"},{"key":"eoi190059r14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2018.09.012","article-title":"Choroideremia gene therapy phase 2 clinical trial: 24-month results.","volume":"197","author":"Lam","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"eoi190059r15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jaapos.2017.06.009","article-title":"Strabismus and binocular diplopia due to advanced glaucomatous visual field loss.","volume":"21","author":"Khanna","year":"2017","journal-title":"J AAPOS"},{"issue":"7","key":"eoi190059r16","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1167\/iovs.08-2926","article-title":"Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease.","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi190059r17","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.2147\/OPTH","article-title":"Recent advances and future prospects in choroideremia.","volume":"9","author":"Zinkernagel","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"eoi190059r18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ophtha.2018.02.004","article-title":"Retinal degeneration in choroideremia follows an exponential decay function.","volume":"125","author":"Aylward","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi190059r19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.eye.6703076","article-title":"Correlation between visual function and photoreceptor inner\/outer segment junction in patients with retinitis pigmentosa.","volume":"23","author":"Aizawa","year":"2009","journal-title":"Eye (Lond)"},{"issue":"8","key":"eoi190059r20","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1167\/iovs.08-2003","article-title":"A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography.","volume":"49","author":"Fischer","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"52","key":"eoi190059r21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005785","article-title":"Structural analysis of retinal photoreceptor ellipsoid zone and postreceptor retinal layer associated with visual acuity in patients with retinitis pigmentosa by ganglion cell analysis combined with OCT imaging.","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"eoi190059r22","first-page":"2507","article-title":"Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography.","volume":"8","author":"Saxena","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"eoi190059r23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/ceo.2016.44.issue-5","article-title":"Ellipsoid zone on optical coherence tomography: a review.","volume":"44","author":"Tao","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"eoi190059r24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40942-017-0082-y","article-title":"Structure versus function: correlation between outer retinal and choroidal thicknesses measured by swept-source OCT with multifocal electroretinography and visual acuity.","volume":"3","author":"Flores-Moreno","year":"2017","journal-title":"Int J Retina Vitreous"},{"issue":"4","key":"eoi190059r25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ajo.2014.05.023","article-title":"Visual acuity and subfoveal choroidal thickness: the Beijing Eye Study.","volume":"158","author":"Shao","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"eoi190059r26","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","article-title":"If nothing goes wrong, is everything all right? interpreting zero numerators.","volume":"249","author":"Hanley","year":"1983","journal-title":"JAMA"},{"key":"eoi190059r10","article-title":"Improved retinal sensitivity in a phase 2 choroideremia gene therapy trial.","author":"Fischer"},{"key":"eoi190059r12","unstructured":"Welcome to Randomization.com!!! http:\/\/www.randomization.com. Accessed January 11, 2016."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2748910\/jamaophthalmology_fischer_2019_oi_190059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T11:01:40Z","timestamp":1573729300000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2748910"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.3278","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}